Valuation: Caplin Point Laboratories Limited

Market Cap 189B 1.95B 1.71B 1.59B 1.46B 2.75B 2.79B 18.94B 7.41B 92.28B 7.34B 7.18B 319B P/E 2026
17.9x
P/E 2027 * 26.4x
Enterprise Value 189B 1.95B 1.71B 1.59B 1.46B 2.75B 2.79B 18.94B 7.41B 92.28B 7.34B 7.18B 319B EV / Sales 2026
5.23x
EV / Sales 2027 * 7.58x
Free-Float
26.39%
Yield 2026 *
-
Yield 2027 * 0.16%
1 day-4.84%
1 week-6.66%
Current month-5.46%
1 month-1.01%
3 months+41.91%
6 months+42.48%
Current year+34.75%
1 week 2,460.1
Extreme 2460.1
2,683.05
1 month 2,460
Extreme 2460
2,700
Current year 1,502.45
Extreme 1502.45
2,700
1 year 1,502.45
Extreme 1502.45
2,700
3 years 838.7
Extreme 838.7
2,700
5 years 575
Extreme 575
2,700
10 years 180
Extreme 180
2,700
Manager TitleAgeSince
Chief Executive Officer 71 2015-03-27
Director of Finance/CFO - 2016-02-18
Chief Administrative Officer - -
Director TitleAgeSince
Chairman 73 2010-01-26
Director/Board Member - 2025-11-04
Director/Board Member 71 2015-03-27
Change 5-day change 1-year change 3-year change Capi.($)
-4.84%-6.66%+18.18%+190.95% 2.06B
-0.96%+0.02%+14.81%+77.10% 48.88B
-0.99%-0.27%+66.69%+108.95% 35.72B
-1.21%-1.60%-3.99%+34.91% 12.02B
-1.47%-0.64%+16.11%+83.68% 11.84B
+0.47%+0.94%+34.42%+136.73% 8.95B
+0.33%-1.13%+50.36%-5.96% 6.91B
-0.34%-2.25%+14.42%+31.69% 6.78B
-1.88%-4.56%+0.69%+192.09% 6.57B
-2.47%-5.28%-33.67%+6.76% 5.81B
Average -1.34%-2.19%+17.80%+85.69% 14.55B
Weighted average by Cap. -1.01%-0.38%+26.45%+83.57%

Financials

2026 2027 *
Net sales 21.28B 221M 193M 179M 165M 311M 315M 2.14B 836M 10.41B 828M 810M 35.97B 24.88B 258M 226M 210M 193M 363M 369M 2.5B 978M 12.17B 968M 947M 42.06B
Net income 6.16B 63.86M 55.95M 51.94M 47.73M 89.94M 91.27M 619M 242M 3.02B 240M 235M 10.42B 7.13B 73.86M 64.72M 60.08M 55.21M 104M 106M 716M 280M 3.49B 277M 271M 12.05B
Net Debt - -
Logo Caplin Point Laboratories Limited
Caplin Point Laboratories Limited is an India-based pharmaceutical company with a business model catering predominantly to emerging markets of Latin America and Africa. The Company has also entered regulated markets such as the United States through its Subsidiary, Caplin Steriles Limited. The Company's operations include research & development and manufacturing of finished formulations, active pharmaceutical ingredients (APIs), clinical research, front-end generic presence in Latin America, brand marketing in Francophone Africa and a USFDA/EU-GMP approved injectable facility. In the Regulated Markets, its products include liquid & lyophilized vials, pre-filled syringes, three-pc ophthalmic droppers and pre-mix bags. In the Emerging Markets, its products include tablets, dry syrups - bottles, soft gels, capsules, suppositories, liquid syrups - bottles, liquid injectables in ampoules & vials, lyophilized vials, prefilled syringes (PFS), and emulsion injection in ampoules & vials.
Employees
3,966
Date Price Change Volume
26-07-22 2,480.95 -4.84% 9,799
26-07-21 ₹2,607.05 -1.54% 3,049
26-07-20 ₹2,647.75 +1.29% 2,358
26-07-17 ₹2,614.00 -2.16% 9,260
26-07-16 ₹2,671.70 +0.78% 19,698
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2,480.95INR
Average target price
2,505.00INR
Spread / Average Target
+0.97%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CAPLIPOINT Stock